Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

Share

Xellia Pharmaceuticals AS

Closing information (x1000 NOK)

Closing information 2023/12 2022/12 2021/12
Turnover 85,872 More Arrow 88,993 Less Arrow 73,253
Financial expenses 13 Less Arrow 3 More Arrow 295
Earnings before taxes 50,609 More Arrow 52,097 Less Arrow 18,676
Total assets 732,234 Less Arrow 680,840 Less Arrow 626,110
Current assets 244,001 Less Arrow 213,041 Less Arrow 180,275
Current liabilities 54,428 Less Arrow 18,698 Less Arrow 15,901
Equity capital 674,435 Less Arrow 658,544 Less Arrow 606,370
- share capital 223,257 Equal arrow 223,257 Equal arrow 223,257

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 92.1% More Arrow 96.7% More Arrow 96.8%
Turnover per employee
Profit as a percentage of turnover 58.9% Less Arrow 58.5% Less Arrow 25.5%
Return on assets (ROA) 6.9% More Arrow 7.7% Less Arrow 3.0%
Current ratio 448.3% More Arrow 1139.4% Less Arrow 1133.7%
Return on equity (ROE) 7.5% More Arrow 7.9% Less Arrow 3.1%
Change turnover -3,121 More Arrow 15,740 Less Arrow -8,267
Change turnover % -4% More Arrow 21% Less Arrow -10%
Chg. No. of employees
Chg. No. of employees %

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.